Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma | Synapse

April 23, 2024Open Access

Ver artículo completo

Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma

MTMonica TangCity College of San Francisco ACAnnabelle R CharbitUniversity of California, San Francisco MJMats W. JohanssonUniversity of Wisconsin–Madison

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The relative utility of eosinophil peroxidase (EPX) and blood and sputum eosinophil counts as disease biomarkers in asthma is uncertain.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Tang et al. (Tue,) studied this question.

synapsesocial.com/papers/68e6de6eb6db64358765a61d https://doi.org/https://doi.org/10.1016/j.jaci.2024.03.023

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Granulocyte Activation Markers in Induced Sputum: Comparison Between Chronic Obstructive Pulmonary Disease, Asthma, and Normal Subjects1997 · 406 citations
2Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust1999 · 34 citations
3Eosinophil granule proteins in peripheral blood granulocytes1992 · 186 citations
4Value of an Additional Review for Eosinophil Quantification in Esophageal Biopsies2015 · 38 citations
5Effect of a bed covering system in children with asthma and house dust mite hypersensitivity1997 · 88 citations